Effects of adrenergic agents on the expression of zebrafish (Danio rerio) vitellogenin Ao1

Toxicology and Applied Pharmacology

Volumn 238, Issue 1, 2009, Pages 20-26

  Yin, Naida ^a,b   Jin, Xia ^a   He, Jiangyan ^a   Yin, Zhan ^a,b  

^a INSTITUTE OF HYDROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Adrenergic agents; Heart; Liver; VtgAo1; Zebrafish

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; APOLIPOPROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; ESTROGEN RECEPTOR ANTAGONIST; ISOPRENALINE; MESSENGER RNA; MOXISYLYTE; PHENYLEPHRINE; TAMOXIFEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITELLOGENIN; VITELLOGENIN AO1;

ADRENERGIC ACTIVITY; ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIPID TRANSPORT; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; TELEOST; ZEBRA FISH;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; ISOPROTERENOL; LIVER; MOXISYLYTE; MYOCARDIUM; PHENYLEPHRINE; RECEPTORS, ESTROGEN; RNA, MESSENGER; TAMOXIFEN; VITELLOGENINS; ZEBRAFISH;

DANIO RERIO; MAMMALIA; TELEOSTEI;

EID: 67349170752     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.04.004     Document Type: Article

References (36)

1. An L., Hu J., Zhu X., Deng B., Zhang Z., and Yang M. Crucian carp (Carassius carassius) VTG monoclonal antibody development and application. Ecotoxicol. Environ. Safety 66 (2007) 148-153
2. Ankley G.T., and Johnson R.D. Small fish models for identifying and assessing the effects of endocrine-disrupting chemicals. ILAR J. 45 (2004) 469-483
3. Babin P.J., Bogerd J., Kooiman F.P., Van Marrewijk W.J.A., and Van der Horst D.J. Apolipophorin II/I, apolipoprotein B, vitellogenin, and microsomal triglyceride transfer protein genes are derived from a common ancestor. J. Mol. Evol. 49 (1999) 150-160
4. Berdougo E., Coleman H., Lee D.H., Stainier D.Y., and Yelon D. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development 130 (2003) 6121-6129
5. Borén J., Véniant M.M., and Young S.G. Apo B100-containing lipoproteins are secreted by the heart. J. Clin. Invest. 101 (1998) 1197-1202
6. Chen J.S., Sappington T.W., and Raikhel A.S. Extensive sequence conservation among insect, nematode, and vertebrate vitellogenins reveals ancient common ancestry. J. Mol. Evol. 44 (1997) 440-451
7. Finn R.N. Vertebrate yolk complexes and the functional implications of phovitins and other subdomains in vitellogenins. Biol. Reprod. 76 (2007) 926-935
8. Finn R.N., and Kristoffersen B.A. Vertebrate vitellogenin gene duplication in relation to the "3R Hypothesis": correlation to the pelagic egg and the oceanic radiation of teleosts. PLoS ONE 2 (2007) e169
9. Hutchinson T.H., Brown R., Brugger K.E., Campbell P.M., Holt M., Länge R., McCahon P., Tattersfield L.J., and van Egmond R. Ecological risk assessment of endocrine disruptors. Environ. Health Perspect. 108 (2000) 1007-1014
10. Huchinson T.H., Ankley G.T., Segner H., and Tyler C.R. Screening and testing for endocrine disruption in fish-biomarkers as "signposts," not "traffic lights," in risk assessment. Environ. Health Perspect. 114 (2006) 106-114
11. Iguchi T., Watanabe H., and Katsu Y. Application of ecotoxicogenomics for studying endocrine disruption in vertebrates and invertebrates. Environ. Health Perspect. 114 (2006) 101-105
12. Islinger M., Willimski D., Vǒlkl A., and Braunbeck T. Effects of 17a-ethinylestradiol on the expression of the three estrogen-responsive genes and cellular ultrastructure of liver and testes in male zebrafish. Aquat. Toxicol. 62 (2003) 85-103
13. Jensen K.M., and Ankley G..T. Evaluation of a commercial kit for measuring vitellogenin in the fathead minnow (Pimephales promelas). Ecotoxicol. Environ. Saf. 64 (2006) 101-105
14. Jung J.H., Jeon J.K., Shim W.J., Oh J.R., Lee J.Y., Kim B.K., and Han C.H. Molecular cloning of vitellogenin cDNA in rockfish (Sebastes schlegeli) and effects of 2,2′4,4′5,5′-hexachlorobiphenyl (PCB 153) on its gene expression. Mar. Pollut. Bulletin 51 (2005) 794-800
15. Kam K.W.L., Qi J.S., Chen M., and Wong T.M. Estrogen reduces cardiac injury and expression of β1-adrenoceptor upon ischemic insult in the rat heart. J. Pharmocol. Exp. Ther. 309 (2004) 8-15
16. Koopman R., Schaart G., and Hesselink M.K.C. Optimisation of Oil Red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem. Cell Biol. 116 (2001) 63-68
17. Leaños-Castañeda O., and Van Der Kraak G. Functional characterization of estrogen receptor subtypes, ERαand ERβ, mediating vitellogenin production in the liver of rainbow trout. Toxicol. Appl. Pharmacol. 224 (2007) 116-125
18. Ma L., Li D., Wang J., He J., and Yin Z. Effects of adrenergic agonists on the extrahepatic expression of vitellogenin Ao1 in heart and brain of the Chinese rare minnow (Gobiocypris rarus). Aquat. Toxicol. 91 (2009) 19-25
19. Masri, S., Lui, K., Phung, S., Ye, J., Zhou, D., Wang, F., Chen, S., 2008. Characterization of the weak estrogen receptor α agonistic activity of exemestane. Breast Cancer Res. Treat Epub ahead of print (DOI 10.10071s10549-008-0151-X).
20. Mikawa N., Utoh T., Horie N., Okamura A., Yamada Y., Akazawa A., Tanaka S., Tsukamoto K., Hirono I., and Aoki T. Cloning and characterization of vitellogenin cDNA from the common Japanese conger (Conger myriaster) and vitellogenin gene expression during ovarian development. Comp. Bioch. Physiol. B 143 (2006) 404-414
21. Miller D.H., Jensen K.M., Villeneuve D.L., Kahl M.D., Makynen E.A., Durhan E.J., and Ankley G.T. Linkage of biochemical responses to population-level effects: a case study with vitellogenin in the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 26 (2007) 521-527
22. Nielsen L.B., Bartels E.D., and Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J. Biol. Chem. 277 (2002) 27014-27020
23. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell Cardiol. 17 (1985) 291-306
24. Sawaguchi S., Koya Y., Yoshizaki N., Ohkubo N., Andoh T., Hiramatsu N., Sullivan C.V., Hara A., and Matsubara T. Multiple vitellogenins (Vgs) in mosquitofish (Gambusia affinis): identification and characterization of three functional Vg genes and their circulating and yolk protein products. Biol. Reprod. 72 (2005) 1045-1060
25. Seguchi O., Takashima S., Yamazaki S., Asakura M., Asano Y., Shintani Y., Wakeno M., Minamino T., Kondo H., Furukawa H., Nakamaru K., Naito A., Takahashi T., Ohtsuka T., Kawakami K., Isomura T., Kitamura S., Tomoike H., Mochizuki N., and Kitakaze M. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J. Clin. Invest. 117 (2007) 2812-2824
26. Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., Floss T., Goettlicher M., Noppinger P.R., Wurst W., Ferrari A., Abrams C.S., Gruber P.J., and Epstein A. Hadc2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat. Med. 13 (2007) 324-331
27. Tong Y., Shan T., Poh Y.K., Yan T., Wang H., Lam S.H., and Gong Z. Molecular cloning of zebrafish and medaka vitellogenin genes and comparison of their expression in response to 17β-estradiol. Gene 328 (2004) 25-36
28. Tyler C.R., Van der Eerden B., Jobling S., Panter G., and Sumpter J.P. Measurement of vitellogenin, a biomarker for exposure to estrogenic chemicals, in a wide variety of cyprinid fish. J. Comp. Physiolo. B 166 (1996) 418-426
29. Van der Ven L.T., Holbech H., Fenske M., Van den Brandhof E., Gielis-Proper F., K., and Van Wester P.W. Vitellogenin expression in zebrafish Danio rerio: evaluation by histochemistry, immunohistochemistry, and in situ mRNA hybridization. Aqua. Toxicol. 65 (2003) 1-11
30. Van der Vusse G.J., Glatz J.F.C., Stam H., C.G., and Reneman R.S. Fatty acid homeostasis in the norMOXIc and ischemic heart. Physiol. Rev 72 (1992) 188-940
31. Wan H., Korzh S., Li Z., Mudumana S.P., Korzh V., Jiang Y.J., Lin S., and Gong Z. Analyses of pancreases development by generation of gfp transgenic zebrafish using exocrine pancreas-specific elastaseA gene promoter. Exp. Cell Res. 412 (2006) 1526-1539
32. Wang H., Yan Y., Tan J.T.T., and Gong Z. A zebrafish vitellogenin gene (vg3) encodes a novel vitellogenin without a phosvitin domain and may represent a primitive vertebrate vitellogenin gene. Gene 256 (2000) 303-310
33. Wang H., Tan J.T.T., Emelyanov A., Korzh V., and Gong Z. Hepatic and extrahepatic expression of vitellogenin genes in the zebrafish, Danio rerio. Gene 356 (2005) 91-100
34. Waring R.H., and Harris R.M. Endocrine disrupters: a human risk? Mol. Cellular Endocrinol. 244 (2005) 2-9
35. Yamauchi T., Iwai M., Kobayashi N., and Shimazu T. Noradrenaline and ATP decrease the secretion of triglyceride and apoprotein B from perfused rat liver. Eyr. J. Physiol. 435 (1998) 368-374
36. Yokoyama M., Yagyu H., Hu Y., Seo T., Hirata K., Homma S., Goldberg I., and J. Apolipoprotein B production reduces lipotoxic cardiomyopathy. J. Biol. Chem. 279 (2004) 4204-4211